Health Condition 1: L700- Acne vulgaris
Conditions
Interventions
Intervention1: Individual Homoeopathic Medicine in Centesimal Potency: Intervention is planned as administering indicated homoeopathic remedies in centesimal potency. Each dose consisted of 1 cane sug
dosage and repetition depending upon the individual requirement of the cases. All medicines will be procured from a Good Manufacturing Practice (GMP)-certified firm.
Intervention2: Individual Homoeopa
Sponsors
THE CALCUTTA HOMOEOPATHIC MEDICAL COLLEGE AND HOSPITAL
Eligibility
Inclusion criteria
Inclusion criteria: 1. All the patients clinically diagnosed as having Acne vulgaris [ICD11 code: ED80] characterised by comedones papules, pastules, nodules on face and trunk. 2. Age 10 to 50 years. 3. Both sexes and transgenders. 4. Patients giving written informed consent (for ages 18 to 50 years)/assent (for ages 10 to 17 years) to participate. 5. Patients with known but controlled systemic disease.
Exclusion criteria
Exclusion criteria: 1. Patients not giving written informed assent and/or consent to participate. 2. Patients using oil-based cosmetics for 6 months. 3. Patients under hormonal treatments. 4. Co-morbid skin conditions like Psoriasis, Lichen planus, eczema etc. 5. Vulnerable population unconscious, non-ambulatory, too sick for consultation, differently abled, terminally or critically ill patients, mentally incompetent people. 6. Pregnant and puerperal women and lactating mothers. 7. Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled or life-threatening illness affecting quality of life or any organ failure. 8. Substance abuse or dependence. 9. Self-reported immune-compromised state. 10. Undergoing homoeopathic treatment for any chronic disease within the last 6 months. 11. Simultaneous participation in any other clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Comparing the effects of individualised homoeopathic medicines prescribed in centesimal potency with individualised homoeopathic medicines prescribed in 50-millesimal potency.Timepoint: At the baseline, and every one month up to 3 months. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Assessment of life quality index. 2. Finding out multifactorial causation.Timepoint: At the baseline, and every one month up to 3 months. | — |
Countries
India
Contacts
Public ContactRajat Chattopadhyay
The Calcutta Homoeopathic Medical College and Hospital
Outcome results
None listed